How is Fingolimod Oral Route dosed?
The typical dosage of Fingolimod oral route for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, is 0.5 mg per day. It is available in both tablet and capsule forms. The tablet form is a disintegrating tablet called Tascenso ODT, and the capsule form is called Gilenya. It should be taken with food and a full glass of water, following the doctor's instructions.
What is the dosage form of Fingolimod Oral Route?
Fingolimod oral route is available in tablet, disintegrating tablet (Tascenso ODT), and capsule (Gilenya) forms.
What medications are contraindication with Fingolimod Oral Route?
Fingolimod oral route is contraindicated with the following medications:
- Infection, acute or chronic, active - should be treated first before starting fingolimod.
- Kidney disease, severe
- Liver disease, severe - use with caution because the effects may be increased due to slower removal of the medicine from the body. Please consult with a healthcare professional for specific interactions and contraindications.
How is Fingolimod Oral Route administered?
Fingolimod oral route is available in both tablet and capsule forms.
What are common precautions when taking Fingolimod Oral Route?
Common precautions when taking Fingolimod orally include:
- Informing your doctor about any allergies, past reactions to medicines, foods, dyes, preservatives, or animals.
- Informing your doctor if you have any kidney or liver problems.
- Avoiding live vaccines while taking Fingolimod and for 2 months after discontinuing the medication.
- Informing your doctor if you are pregnant, planning to become pregnant, or are breastfeeding.
- Reporting any side effects to your healthcare professional. Please consult with your healthcare professional for personalized advice.